Butterfly Medical raises $21m in funds for BPH device development
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device…
15 May 2026
Biopharma industry endorses Pazdur for FDA commissioner role
With the leadership role of the US Food and Drug Administration (FDA) vacant following Marty Makary’s resignation earlier this week, leaders across the biopharma industry have shared their support for…
15 May 2026
BlueWind Medical raises $47.8m to advance commercialisation efforts for UUI treatment
BlueWind Medical has raised $47.8m to expand commercialisation of its implantable tibial neuromodulation (iTNM) system for urge urinary incontinence (UUI) treatment. Originating through a combination of equity and debt financing, the…
15 May 2026
Ardent Health and Fujifilm team up for Synapse enterprise imaging rollout
Ardent Health has partnered with Fujifilm Healthcare to bring Synapse enterprise imaging solutions to its acute care hospitals across six US states. The partnership between Ardent Health and Fujifilm Healthcare…
14 May 2026
UK health secretary Wes Streeting resigns
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister Keir Starmer following the party’s significant losses in last week’s…
14 May 2026
UroMems eyes regulatory filings for SUI treatment after $60m fundraise
UroMems has raised $60m, priming the French company to complete a pivotal trial of its stress urinary incontinence (SUI) treatment, the data from which will support regulatory filings for the…
14 May 2026
AngioDynamics reports PRESERVE trial results for NanoKnife system
AngioDynamics has reported two-year findings from the PRESERVE pivotal trial, showing durable outcomes for the NanoKnife irreversible electroporation (IRE) system in treating intermediate-risk prostate cancer. The single-arm, prospective pivotal investigational…